Nieuws
Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...
The Synchron Stentrode device is still in clinical trials and has been in development since 2012. Synchron achieved the first BCI in 2019. In March, they and NVIDIA announced Chiral, a foundation ...
Comments below Ted’s Strata-gee article, from an anonymous commenter, said that the FBI had visited the Masimo Irvine headquarters, which lines up with the last sentence of the first paragraph. The ...
Telehealth and Telecare News since 2005 ...
Adjusted EBITDA for Q1 decreased 8% to $58.1 million, versus $63.1 million in the prior year. \ Integrated Care’s adjusted EBITDA increased 6% to $50.4 million. BetterHelp’s adjusted EBITDA decreased ...
Resultaten die mogelijk niet toegankelijk zijn voor u worden momenteel weergegeven.
Niet-toegankelijke resultaten verbergen